Russell M Viner1, Oliver T Mytton2, Chris Bonell3, G J Melendez-Torres4, Joseph Ward1, Lee Hudson1, Claire Waddington5, James Thomas6, Simon Russell1, Fiona van der Klis7, Archana Koirala8, Shamez Ladhani9, Jasmina Panovska-Griffiths10, Nicholas G Davies3, Robert Booy8, Rosalind M Eggo3. 1. UCL Great Ormond Street Institute of Child Health, London, United Kingdom. 2. MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom. 3. London School of Hygiene and Tropical Medicine, London, United Kingdom. 4. College of Medicine and Health, University of Exeter, Exeter, United Kingdom. 5. Department of Medicine, University of Cambridge, Cambridge, United Kingdom. 6. UCL Institute of Education, London, United Kingdom. 7. National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. 8. University of Sydney, Sydney, Australia. 9. St George's University of London, London, United Kingdom. 10. Department of Applied Health Research, University College London, London, United Kingdom.
Abstract
Importance: The degree to which children and adolescents are infected by and transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. The role of children and adolescents in transmission of SARS-CoV-2 is dependent on susceptibility, symptoms, viral load, social contact patterns, and behavior. Objective: To systematically review the susceptibility to and transmission of SARS-CoV-2 among children and adolescents compared with adults. Data Sources: PubMed and medRxiv were searched from database inception to July 28, 2020, and a total of 13 926 studies were identified, with additional studies identified through hand searching of cited references and professional contacts. Study Selection: Studies that provided data on the prevalence of SARS-CoV-2 in children and adolescents (younger than 20 years) compared with adults (20 years and older) derived from contact tracing or population screening were included. Single-household studies were excluded. Data Extraction and Synthesis: PRISMA guidelines for abstracting data were followed, which was performed independently by 2 reviewers. Quality was assessed using a critical appraisal checklist for prevalence studies. Random-effects meta-analysis was undertaken. Main Outcomes and Measures: Secondary infection rate (contact-tracing studies) or prevalence or seroprevalence (population screening studies) among children and adolescents compared with adults. Results: A total of 32 studies comprising 41 640 children and adolescents and 268 945 adults met inclusion criteria, including 18 contact-tracing studies and 14 population screening studies. The pooled odds ratio of being an infected contact in children compared with adults was 0.56 (95% CI, 0.37-0.85), with substantial heterogeneity (I2 = 94.6%). Three school-based contact-tracing studies found minimal transmission from child or teacher index cases. Findings from population screening studies were heterogenous and were not suitable for meta-analysis. Most studies were consistent with lower seroprevalence in children compared with adults, although seroprevalence in adolescents appeared similar to adults. Conclusions and Relevance: In this meta-analysis, there is preliminary evidence that children and adolescents have lower susceptibility to SARS-CoV-2, with an odds ratio of 0.56 for being an infected contact compared with adults. There is weak evidence that children and adolescents play a lesser role than adults in transmission of SARS-CoV-2 at a population level. This study provides no information on the infectivity of children.
Importance: The degree to which children and adolescents are infected by and transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. The role of children and adolescents in transmission of SARS-CoV-2 is dependent on susceptibility, symptoms, viral load, social contact patterns, and behavior. Objective: To systematically review the susceptibility to and transmission of SARS-CoV-2 among children and adolescents compared with adults. Data Sources: PubMed and medRxiv were searched from database inception to July 28, 2020, and a total of 13 926 studies were identified, with additional studies identified through hand searching of cited references and professional contacts. Study Selection: Studies that provided data on the prevalence of SARS-CoV-2 in children and adolescents (younger than 20 years) compared with adults (20 years and older) derived from contact tracing or population screening were included. Single-household studies were excluded. Data Extraction and Synthesis: PRISMA guidelines for abstracting data were followed, which was performed independently by 2 reviewers. Quality was assessed using a critical appraisal checklist for prevalence studies. Random-effects meta-analysis was undertaken. Main Outcomes and Measures: Secondary infection rate (contact-tracing studies) or prevalence or seroprevalence (population screening studies) among children and adolescents compared with adults. Results: A total of 32 studies comprising 41 640 children and adolescents and 268 945 adults met inclusion criteria, including 18 contact-tracing studies and 14 population screening studies. The pooled odds ratio of being an infected contact in children compared with adults was 0.56 (95% CI, 0.37-0.85), with substantial heterogeneity (I2 = 94.6%). Three school-based contact-tracing studies found minimal transmission from child or teacher index cases. Findings from population screening studies were heterogenous and were not suitable for meta-analysis. Most studies were consistent with lower seroprevalence in children compared with adults, although seroprevalence in adolescents appeared similar to adults. Conclusions and Relevance: In this meta-analysis, there is preliminary evidence that children and adolescents have lower susceptibility to SARS-CoV-2, with an odds ratio of 0.56 for being an infected contact compared with adults. There is weak evidence that children and adolescents play a lesser role than adults in transmission of SARS-CoV-2 at a population level. This study provides no information on the infectivity of children.
Authors: Jill E Weatherhead; Eva Clark; Tiphanie P Vogel; Robert L Atmar; Prathit A Kulkarni Journal: J Clin Invest Date: 2020-12-01 Impact factor: 14.808
Authors: Christine M Szablewski; Karen T Chang; Clinton J McDaniel; Victoria T Chu; Anna R Yousaf; Noah G Schwartz; Marie Brown; Kathryn Winglee; Prabasaj Paul; Zhaohui Cui; Rachel B Slayton; Suxiang Tong; Yan Li; Anna Uehara; Jing Zhang; Sarah M Sharkey; Hannah L Kirking; Jacqueline E Tate; Emilio Dirlikov; Alicia M Fry; Aron J Hall; Dale A Rose; Julie Villanueva; Cherie Drenzek; Rebekah J Stewart; Tatiana M Lanzieri Journal: Pediatrics Date: 2021-01-27 Impact factor: 7.124
Authors: Matt J Keeling; Michael J Tildesley; Benjamin D Atkins; Bridget Penman; Emma Southall; Glen Guyver-Fletcher; Alex Holmes; Hector McKimm; Erin E Gorsich; Edward M Hill; Louise Dyson Journal: Philos Trans R Soc Lond B Biol Sci Date: 2021-05-31 Impact factor: 6.237
Authors: Marco Roversi; Umberto Raucci; Giuseppe Pontrelli; Stefania Ranno; Michela Ambrosi; Antonio Torelli; Mara Pisani; Luana Coltella; Livia Piccioni; Luna Colagrossi; Marilena Agosta; Barbara Scialanga; Antonino Reale; Carlo Federico Perno; Paolo Rossi; Alberto Villani Journal: Pediatr Res Date: 2021-06-11 Impact factor: 3.953